---
category: news
title: "Israeli innovation lab backed by pharmaceutical, biotech giants mints 1st AI startup"
excerpt: "AION Labs, a Rehovot-based consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company that will help drug firms improve chances of success in clinical trials"
publishedDateTime: 2022-09-28T11:13:00Z
originalUrl: "https://www.timesofisrael.com/israeli-innovation-lab-backed-by-pharmaceutical-biotech-giants-mints-1st-ai-startup/"
webUrl: "https://www.timesofisrael.com/israeli-innovation-lab-backed-by-pharmaceutical-biotech-giants-mints-1st-ai-startup/"
ampWebUrl: "https://www.timesofisrael.com/israeli-innovation-lab-backed-by-pharmaceutical-biotech-giants-mints-1st-ai-startup/amp/"
cdnAmpWebUrl: "https://www-timesofisrael-com.cdn.ampproject.org/c/s/www.timesofisrael.com/israeli-innovation-lab-backed-by-pharmaceutical-biotech-giants-mints-1st-ai-startup/amp/"
type: article
quality: 50
heat: 60
published: false

provider:
  name: The Times of Israel
  domain: timesofisrael.com

topics:
  - AI

images:
  - url: "https://static.timesofisrael.com/www/uploads/2022/09/Aion-_-Portraits-_-by-Elad-Malka-4509-640x400.jpg"
    width: 640
    height: 400
    isCached: true

related:
  - title: "AION Labs launches AI startup to improve drug trials"
    excerpt: "AION Labs has formed OMEC.AI, the labâ€™s first startup approved by the Israel Innovation Authority. The new company will develop AI-powered solutions to analyze pre-clinical data and identify gaps in efficacy and safety to improve the probability of success of drug candidates in clinical trials."
    publishedDateTime: 2022-09-28T19:57:00Z
    webUrl: "https://www.labiotech.eu/trends-news/aion-labs-launches-ai-startup-improve-drug-trials/"
    type: article
    provider:
      name: labiotech
      domain: labiotech.eu
    quality: 37
    images:
      - url: "https://www.labiotech.eu/wp-content/uploads/2022/06/shutterstock-artificial-intelligence-.jpg"
        width: 1024
        height: 683
        isCached: true

secured: "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;9xsOcTL9PSF353T8g+sGPQ=="
---

